-
Real Time Chart
-
Stock Profile
-
Stock Fundamentals
Financials As Reported
-
accession Number
0001558370-23-008510
-
accounts Payable Current
5,441,000
-
accounts Receivable Net Current
21,124,000
-
allocated Share Based Compensation Expense
4,572,000
-
amendment Flag
false
-
assets
128,573,000
-
assets Current
107,162,000
-
cash And Cash Equivalents At Carrying Value
79,026,000
-
cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
80,790,000
-
cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
--23,274,000
-
cik
1,393,434
-
city Area Code
781
-
common Stock Par Or Stated Value Per Share
0.0001
-
common Stock Shares Authorized
200,000,000
-
common Stock Shares Issued
77,516,638
-
common Stock Shares Outstanding
77,516,638
-
contract With Customer Liability
13,803,000
-
contract With Customer Liability Current
463,000
-
contract With Customer Liability Revenue Recognized
160,000
-
cost Of Goods And Services Sold
1,214,000
-
current Fiscal Year End Date
--12-31
-
date Filed
2023-05-08
-
depreciation Depletion And Amortization
483,000
-
document Fiscal Period Focus
Q1
-
document Fiscal Year Focus
2,023
-
document Period End Date
2023-03-31
-
document Transition Report
false
-
document Type
10-Q
-
earnings Per Share Basic
-0.39
-
earnings Per Share Diluted
-0.39
-
employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
26,118,000
-
employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition 1
P2Y6M29D
-
entity Address Address Line 1
24 Crosby Drive
-
entity Address City Or Town
Bedford
-
entity Address Postal Zip Code
1,730
-
entity Address State Or Province
MA
-
entity Central Index Key
1,393,434
-
entity Current Reporting Status
Yes
-
entity Emerging Growth Company
false
-
entity File Number
001-36554
-
entity Filer Category
Non-accelerated Filer
-
entity Incorporation State Country Code
DE
-
entity Interactive Data Current
Yes
-
entity Name
OCULAR THERAPEUTIX, INC
-
entity Registrant Name
Ocular Therapeutix, Inc.
-
entity Shell Company
false
-
entity Small Business
true
-
entity Tax Identification Number
20-5560161
-
increase Decrease In Accounts Payable
1,025,000
-
increase Decrease In Accounts Receivable
--201,000
-
increase Decrease In Contract With Customer Liability
--160,000
-
increase Decrease In Inventories
292,000
-
interest Expense
1,768,000
-
interest Paid Net
701,000
-
inventory Net
2,266,000
-
irs Number
0
-
liabilities
118,862,000
-
liabilities And Stockholders Equity
128,573,000
-
liabilities Current
29,715,000
-
local Phone Number
357-4000
-
net Cash Provided By Used In Financing Activities
78,000
-
net Cash Provided By Used In Investing Activities
--3,379,000
-
net Cash Provided By Used In Operating Activities
--19,973,000
-
net Income Loss
--30,318,000
-
nonoperating Income Expense
--7,769,000
-
operating Income Loss
--22,549,000
-
operating Lease Liability Current
1,818,000
-
operating Lease Liability Noncurrent
8,114,000
-
operating Lease Right Of Use Asset
7,625,000
-
other Liabilities Noncurrent
100,000
-
other Nonoperating Income Expense
--1,000
-
payments To Acquire Property Plant And Equipment
3,379,000
-
period End
1,680,220,800,000
-
period Start
1,672,531,200,000
-
property Plant And Equipment Net
12,022,000
-
report Link
https://www.sec.gov/Archives/edgar/data/1393434/000155837023008510/ocul-20230331x10q_htm.xml
-
research And Development Expense
14,747,000
-
retained Earnings Accumulated Deficit
--647,160,000
-
revenue From Contract With Customer Excluding Assessed Tax
13,374,000
-
share Based Compensation
4,572,000
-
stockholders Equity
9,711,000
-
trading Symbol
OCUL
-
update
1970-01-01
-
weighted Average Number Of Diluted Shares Outstanding
77,386,287
-
weighted Average Number Of Shares Outstanding Basic
77,386,287
-
id
REPORTED_FINANCIALS
-
key
OCUL
-
subkey
10-Q
-
date
2023-05-08
-
updated
2023-05-09
-
Symbol Info
-
Symbol Over View
-
Technical Analysis
OCUL stock fundamentals - financials as reported